128 related articles for article (PubMed ID: 32188898)
41. Identification of a short, single site matriglycan that maintains neuromuscular function in the mouse.
Yang T; Chandel I; Gonzales M; Okuma H; Prouty SJ; Zarei S; Joseph S; Garringer KW; Landa SO; Yonekawa T; Walimbe AS; Venzke DP; Anderson ME; Hord JM; Campbell KP
bioRxiv; 2023 Dec; ():. PubMed ID: 38187633
[TBL] [Abstract][Full Text] [Related]
42. Human ISPD Is a Cytidyltransferase Required for Dystroglycan O-Mannosylation.
Riemersma M; Froese DS; van Tol W; Engelke UF; Kopec J; van Scherpenzeel M; Ashikov A; Krojer T; von Delft F; Tessari M; Buczkowska A; Swiezewska E; Jae LT; Brummelkamp TR; Manya H; Endo T; van Bokhoven H; Yue WW; Lefeber DJ
Chem Biol; 2015 Dec; 22(12):1643-52. PubMed ID: 26687144
[TBL] [Abstract][Full Text] [Related]
43. Involvement of abnormal dystroglycan expression and matriglycan levels in cancer pathogenesis.
Quereda C; Pastor À; Martín-Nieto J
Cancer Cell Int; 2022 Dec; 22(1):395. PubMed ID: 36494657
[TBL] [Abstract][Full Text] [Related]
44. Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression.
Sgambato A; Migaldi M; Montanari M; Camerini A; Brancaccio A; Rossi G; Cangiano R; Losasso C; Capelli G; Trentini GP; Cittadini A
Am J Pathol; 2003 Mar; 162(3):849-60. PubMed ID: 12598319
[TBL] [Abstract][Full Text] [Related]
45. A role of fukutin, a gene responsible for Fukuyama type congenital muscular dystrophy, in cancer cells: a possible role to suppress cell proliferation.
Yamamoto T; Kato Y; Shibata N; Sawada T; Osawa M; Kobayashi M
Int J Exp Pathol; 2008 Oct; 89(5):332-41. PubMed ID: 18808525
[TBL] [Abstract][Full Text] [Related]
46. Expression of glycosylated α-dystroglycan in newborn skeletal and cardiac muscles of fukutin related protein (FKRP) mutant mice.
Keramaris E; Lu PJ; Tucker J; Lu QL
Muscle Nerve; 2017 Apr; 55(4):582-590. PubMed ID: 27515093
[TBL] [Abstract][Full Text] [Related]
47. Ribitol alters multiple metabolic pathways of central carbon metabolism with enhanced glycolysis: A metabolomics and transcriptomics profiling of breast cancer.
Tucker JD; Doddapaneni R; Lu PJ; Lu QL
PLoS One; 2022; 17(12):e0278711. PubMed ID: 36477459
[TBL] [Abstract][Full Text] [Related]
48. A role for dystroglycan in the pathophysiology of acute leukemic cells.
Alonso-Rangel L; Benítez-Guerrero T; Martínez-Vieyra I; Cisneros B; Martínez-Tovar A; Winder SJ; Cerecedo D
Life Sci; 2017 Aug; 182():1-9. PubMed ID: 28591567
[TBL] [Abstract][Full Text] [Related]
49. Increased expression of dystroglycan inhibits the growth and tumorigenicity of human mammary epithelial cells.
Sgambato A; Camerini A; Faraglia B; Pavoni E; Montanari M; Spada D; Losasso C; Brancaccio A; Cittadini A
Cancer Biol Ther; 2004 Oct; 3(10):967-75. PubMed ID: 15467432
[TBL] [Abstract][Full Text] [Related]
50. Loss of LARGE2 disrupts functional glycosylation of α-dystroglycan in prostate cancer.
Esser AK; Miller MR; Huang Q; Meier MM; Beltran-Valero de Bernabé D; Stipp CS; Campbell KP; Lynch CF; Smith BJ; Cohen MB; Henry MD
J Biol Chem; 2013 Jan; 288(4):2132-42. PubMed ID: 23223448
[TBL] [Abstract][Full Text] [Related]
51. Direct Mapping of Additional Modifications on Phosphorylated O-glycans of α-Dystroglycan by Mass Spectrometry Analysis in Conjunction with Knocking Out of Causative Genes for Dystroglycanopathy.
Yagi H; Kuo CW; Obayashi T; Ninagawa S; Khoo KH; Kato K
Mol Cell Proteomics; 2016 Nov; 15(11):3424-3434. PubMed ID: 27601598
[TBL] [Abstract][Full Text] [Related]
52. Matriglycan: a novel polysaccharide that links dystroglycan to the basement membrane.
Yoshida-Moriguchi T; Campbell KP
Glycobiology; 2015 Jul; 25(7):702-13. PubMed ID: 25882296
[TBL] [Abstract][Full Text] [Related]
53. Distinct expression of functionally glycosylated alpha-dystroglycan in muscle and non-muscle tissues of FKRP mutant mice.
Blaeser A; Awano H; Lu P; Lu QL
PLoS One; 2018; 13(1):e0191016. PubMed ID: 29320543
[TBL] [Abstract][Full Text] [Related]
54. Limb girdle muscular dystrophy type 2I: No correlation between clinical severity, histopathology and glycosylated α-dystroglycan levels in patients homozygous for common FKRP mutation.
Alhamidi M; Brox V; Stensland E; Liset M; Lindal S; Nilssen Ø
Neuromuscul Disord; 2017 Jul; 27(7):619-626. PubMed ID: 28479227
[TBL] [Abstract][Full Text] [Related]
55. Dystroglycanopathy muscles lacking functional glycosylation of alpha-dystroglycan retain regeneration capacity.
Awano H; Blaeser A; Wu B; Lu P; Keramaris-Vrantsis E; Lu Q
Neuromuscul Disord; 2015 Jun; 25(6):474-84. PubMed ID: 25937147
[TBL] [Abstract][Full Text] [Related]
56. A tumor suppressor function of laminin-binding alpha-dystroglycan.
Bao X; Fukuda M
Methods Enzymol; 2010; 479():387-96. PubMed ID: 20816178
[TBL] [Abstract][Full Text] [Related]
57. Fukutin-related protein is essential for mouse muscle, brain and eye development and mutation recapitulates the wide clinical spectrums of dystroglycanopathies.
Chan YM; Keramaris-Vrantsis E; Lidov HG; Norton JH; Zinchenko N; Gruber HE; Thresher R; Blake DJ; Ashar J; Rosenfeld J; Lu QL
Hum Mol Genet; 2010 Oct; 19(20):3995-4006. PubMed ID: 20675713
[TBL] [Abstract][Full Text] [Related]
58. Mouse large can modify complex N- and mucin O-glycans on alpha-dystroglycan to induce laminin binding.
Patnaik SK; Stanley P
J Biol Chem; 2005 May; 280(21):20851-9. PubMed ID: 15788414
[TBL] [Abstract][Full Text] [Related]
59. α-Dystroglycan hypoglycosylation affects cell migration by influencing β-dystroglycan membrane clustering and filopodia length: A multiscale confocal microscopy analysis.
Palmieri V; Bozzi M; Signorino G; Papi M; De Spirito M; Brancaccio A; Maulucci G; Sciandra F
Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2182-2191. PubMed ID: 28572004
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
